Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy

M1003
HCPCS Code

2023 HCPCS
Billable/Valid Code

M1003 is a valid 2023 HCPCS Code that could be used to indicate Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for reimbursement purposes.

M1003 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2021.

Short description for M1003 HCPCS code:

Tb scr 12 mo pri fst bio dz

HCPCS M1003

M1003 code information

HCPCS code:	M1003
Description:	TB SCREENING PERFORMED AND RESULTS INTERPRETED WITHIN TWELVE MONTHS PRIOR TO INITIATION OF FIRST-TIME BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG THERAPY
Effective Date:	Jan 01, 2021
Added Date:	Jan 01, 2019
Termination Date:	HCPCS M1003 was terminated on Nov 30, -0001
Pricing indicator:	`00` - SERVICE NOT SEPARATELY PRICED BY PART B (E.G., SERVICES NOT COVERED, BUNDLED, USED BY PART A ONLY, ETC.) PHYSICIAN FEE SCHEDULE AND NON-PHYSICIAN PRACTITIONERS
Multi Pricing indicator:	`9` - NOT APPLICABLE AS HCPCS NOT PRICED SEPARATELY BY PART B (PRICING INDICATOR IS 00) OR VALUE IS NOT ESTABLISHED (PRICING INDICATOR IS ´99´)
Coverage code:	`C` - CARRIER JUDGMENT
BETOS code:	`Z2` - UNDEFINED CODES
Action code:	`C` - CHANGE IN LONG DESCRIPTION OF PROCEDURE OR MODIFIER CODE
Type of Service:	`1` - MEDICAL CARE
Anesthesia BUQ:	0